141 related articles for article (PubMed ID: 1964762)
1. Anti-inflammatory properties of a novel wound healing and immunomodulating agent, tetrachlorodecaoxygen complex (TCDO).
Tissot M; Roch-Arveiller M; Mathieu J; Giroud JP; Stahl KW
Agents Actions; 1990 Nov; 31(3-4):368-74. PubMed ID: 1964762
[TBL] [Abstract][Full Text] [Related]
2. Local and systemic effects of an acute inflammation on eicosanoid generation capacity of polymorphonuclear cells and macrophages.
Mathieu J; Tissot M; Nolibe D; Florentin I; Kergonou JF; Giroud JP
Int J Exp Pathol; 1990 Oct; 71(5):603-16. PubMed ID: 2169856
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of prostaglandin production in the inflammatory tissue by loxoprofen-Na, an anti-inflammatory prodrug.
Sugimoto M; Kojima T; Asami M; Iizuka Y; Matsuda K
Biochem Pharmacol; 1991 Nov; 42(12):2363-8. PubMed ID: 1764120
[TBL] [Abstract][Full Text] [Related]
4. Tetrachlorodecaoxygen, a wound healing agent, produces vascular relaxation through hemoglobulin-dependent inactivation of serotonin and norepinephrine.
Wolin MS; Kleber E; Mohazzab KM; Elstner EF
J Cardiovasc Pharmacol; 1994 Apr; 23(4):664-8. PubMed ID: 7516020
[TBL] [Abstract][Full Text] [Related]
5. Anti-inflammatory effect of magnolol, isolated from Magnolia officinalis, on A23187-induced pleurisy in mice.
Wang JP; Ho TF; Chang LC; Chen CC
J Pharm Pharmacol; 1995 Oct; 47(10):857-60. PubMed ID: 8583356
[TBL] [Abstract][Full Text] [Related]
6. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
7. Rationale for and results from a randomised, double-blind trial of tetrachlorodecaoxygen anion complex in wound healing.
Hinz J; Hautzinger H; Stahl KW
Lancet; 1986 Apr; 1(8485):825-8. PubMed ID: 2870315
[TBL] [Abstract][Full Text] [Related]
8. The tetrachlorodecaoxygen complex reverses the effect of cortisone on wound healing.
Hatz RA; Kelley SF; Ehrlich HP
Plast Reconstr Surg; 1989 Dec; 84(6):953-9. PubMed ID: 2587659
[TBL] [Abstract][Full Text] [Related]
9. [Effects of tetrachlorodecaoxide (TCDO) in chronic radiation lesions of the rat colon].
Sassy T; Breiter N; Trott KR
Strahlenther Onkol; 1991 Mar; 167(3):191-6. PubMed ID: 2014474
[TBL] [Abstract][Full Text] [Related]
10. Release of leukotriene B4 and 6-keto-prostaglandin F1 alpha from rat leukocytes in response to platelet-activating factor or Ca-ionophore A23187.
Yamaki K; Oh-ishi S
J Lipid Mediat; 1990; 2(6):317-27. PubMed ID: 1966808
[TBL] [Abstract][Full Text] [Related]
11. Effect of norathyriol, isolated from Tripterospermum lanceolatum, on A23187-induced pleurisy and analgesia in mice.
Wang JP; Ho TF; Lin CN; Teng CM
Naunyn Schmiedebergs Arch Pharmacol; 1994 Jul; 350(1):90-5. PubMed ID: 7935860
[TBL] [Abstract][Full Text] [Related]
12. Characterization of the induction of nitric oxide synthase and cyclo-oxygenase in rat aorta in organ culture.
Bishop-Bailey D; Larkin SW; Warner TD; Chen G; Mitchell JA
Br J Pharmacol; 1997 May; 121(1):125-33. PubMed ID: 9146896
[TBL] [Abstract][Full Text] [Related]
13. Rickettsial effects on leukotriene and prostaglandin secretion by mouse polymorphonuclear leukocytes.
Walker TS; Hoover CS
Infect Immun; 1991 Jan; 59(1):351-6. PubMed ID: 1846125
[TBL] [Abstract][Full Text] [Related]
14. Antimicrobial effects of the tetrachlorodecaoxygen-anion complex on oropharyngeal bacterial flora: an in vitro study.
Stoll P; Huber H; Pelz K; Weingart D
Chemotherapy; 1993; 39(1):40-7. PubMed ID: 8444059
[TBL] [Abstract][Full Text] [Related]
15. Increased resistance towards two systemic experimental infections by tetrachlorodecaoxygen anion complex. Possible implications of cellular and humoral immunity.
Gillissen G; Kühne FW; Breuer-Werle M; Melzer B; Ostendorp H
Arzneimittelforschung; 1986 Dec; 36(12):1778-82. PubMed ID: 3566839
[TBL] [Abstract][Full Text] [Related]
16. Effects of some non-steroidal anti-inflammatory drug copper complexes on polymorphonuclear leukocyte oxidative metabolism.
Roch-Arveiller M; Revelant V; Pham Huy D; Maman L; Fontagne J; Sorenson JR; Giroud JP
Agents Actions; 1990 Aug; 31(1-2):65-71. PubMed ID: 2178320
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of extravasation necroses as a complication following intravenous cytostatic drug therapy. Results of an open pilot study].
Kolarić K; Zupanc D; Stahl KW; Hinz J; Kempf SR; Ivankovic S
Onkologie; 1988 Oct; 11(5):238-40. PubMed ID: 3059251
[TBL] [Abstract][Full Text] [Related]
18. Effect of a novel non-steroidal anti-inflammatory drug (M-5011) on cytokine levels in rats with monosodium urate crystal- induced pleurisy.
Murakami N; Aihara S; Iwata K; Saito T; Naruse T
Jpn J Pharmacol; 1999 Apr; 79(4):439-46. PubMed ID: 10361883
[TBL] [Abstract][Full Text] [Related]
19. Atropa acuminata Royle Ex Lindl. blunts production of pro-inflammatory mediators eicosanoids., leukotrienes, cytokines in vitro and in vivo models of acute inflammatory responses.
Nisar A; Malik AH; Zargar MA
J Ethnopharmacol; 2013 Jun; 147(3):584-94. PubMed ID: 23528361
[TBL] [Abstract][Full Text] [Related]
20. Impaired leukotriene B4 release by neonatal polymorphonuclear leukocytes.
Viggiano D; Romano G; Caniglia M; Santoro P; Palumbo A; Ciccimarra F
Pediatr Res; 1994 Jul; 36(1 Pt 1):60-3. PubMed ID: 7936838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
